The use of practolol in the management of coronary insufficiency and hypertension in the early 1970s resulted in the syndrome of skin rash, deafness, dry eyes, and pleural and peritoneal effusion and fibrosis (oculomucocutaneous syndrome) in some patients taking the drug.' The ocular involvement, although variable in extent, was associated with reduction in tear production, reduction in lysozyme content of the tear film, and conjunctival fibrosis. The persistent and troublesome nature of the dry eyes experienced by some of these patients has resulted in their being obliged to use tear substitutes constantly. In many cases drops have to be instilled every 15-20 minutes throughout the day and occasionally during the night.
Many different agents and systems have been tried in the management of the extremely dry eye and the OMC syndrome is probably the severest form of this condition. So far no On their first visit a history was taken including specific questions about their past and present therapy and its frequency. The patients were asked to score their current symptoms as absent, mild, moderate, or severe. The following symptoms were evaluated by direct questioning: grittiness, burning, photophobia, effect of irritants (e.g., wind and smoke), dryness, discharge, itching, aching, lid swelling.
The visual acuity was recorded. The precorneal tear film was scored for marginal strip thickness, debris, and mucus. The bulbar and palpebral conjunctiva was scored for hyperaemic follicles, papillae etc. and fornix shortening. The cornea was examined, and any abnormalities were noted and scored.
The eyes were then stained with rose Bengal 1%, the excess being irrigated away with physiological saline, after which the staining of the cornea and conjunctiva was recorded.
The patients were then instructed in the insertion of the inserts with the applicator provided. They were told to insert one each morning in each eye, to use their usual tear substitutes if their symptoms warranted it, and that they could use as many inserts during the day as they found necessary for comfort.
They were seen a week later (week 1), 2 weeks after that (week 3), and then finally (week 5). The eyes were fully examined as described above at each visit, but the symptom check was completed only on the final visit.
Results
A total of 11 patients entered the analysis, of whom 3 were male and 8 female. Their average age was 64 5 years. Five patients completed the protocol.
At the prestudy examination all the patients but one were using tear substitutes more frequently than every half hour. Four patients were using alkaline drops, the remainder were using physiological saline drops without preservative. In addition 6 patients were also using gutt. acetylcysteine of various concentrations, and 2 were using gutt. predsol. Punctal occlusion had been carried out in every case.
All the patients had some evidence of conjunctival fibrosis, but none had more than moderate fornix shortening. Most patients were taking concurrent therapy for their cardiovascular insufficiency and related problems. None of these are currently known to affect tear physiology adversely. All stopped taking practolol in 1974-5, and the average period for which practolol was taken was 3 years.
All observations and symptoms were scored at 0= absent, 1=just present, 2=moderate, 3=severe/ considerable. The rose Bengal staining was charted at the time of examination but was not scored until the study was completed, at which time all the records were scored at one session. The results expressed as mean scores for the prestudy examination and final (week 5) examination are shown in Table 1 . Fig. 3 shows the scoring for precorneal tear film and marginal strip and Fig. 4 shows the scoring f9r rose Bengal staining.
All the patientetering the study had some degree of fornix shortening due to the fibrosis of the OMC syndrome. All except one patient experienced some difficulty from ejection of the inserts, but all found a means of overcoming this, and no patients left the study purely because they were unable to retain the inserts.
All those patients who stopped using inserts before the end of the protocol reported that their drops gave moreinstantreliefthan did the inserts. Three patients reported a greater cooling and soothing effect from instillation of drops than they got from the inserts. Two patients left the study because they were unable to tolerate the inserts. One patient reported an increase in frequency ofinstillation of drops one week after starting using the inserts and was withdrawn.
No local or systemic adverse reaction resulted from the use of up to 5 dry-eye inserts per day in the patients studied. There was no change in the slit-lamp appearance of the inferior fomix. The visual acuity remained unaltered on average during the study.
Discussion
We chose this group of patients for this, the first, trial of the dry-eye inserts in the UK mainly because they were so severely handicapped and because they were well documented. They were chosen for inclusion much as one would choose patients for any clinical treatment. It certainly became apparent that in the course of 7 or 8 years many of these patients had come to rely on their drops for cooling and soothing effects at least as much as for hydration and lubrication. That only about half the patients completed the protocol is roughly in line with findings in contact lens tolerance and may be considered more a comment on the acceptability of inserting any solid object into the eye. Others have found a higher level of acceptance than we found, but their studies were with keratoconjunctivitis sicca. Breslin et al.7 reported that 4 out of24 patients with keratoconjunctivitis sicca withdrew from their study because of symptoms related to the inserts. Two of their patients reported intolerable blurring of vision sufficient to stop them from using the inserts. Nobody in our series found this to be a problem, though many of our patients had a considerable degree of visual impairment (mean 6/24) before entering the study.
In a cross-over study comparing slow-release artificial tear inserts with liquid artificial tears Katz et al. 6 found that 78% of their 32 keratoconjunctivitis sicca patients preferred inserts to drops, with only 5 patients out of a 47-patient long-term trial of inserts dropping out. One of their patients dropped out because of rheumatoid arthritis affecting his ability to insert the inserts and another because of bilateral aphakia. Others who dropped out did so because of blurring of vision due to the polymer in the tear film, although most who reported this-usually 4-6 hours after insertion-coped with it by removing the remaining portions of the insert without any diminution of the stabilising and lubricating effect.
Lamberts et al.5 reported that 18 of 37 patients in a long-term study of up to 18 months were happy to continue on the inserts. They found a significant increase in tear meniscus height after inserts compared with drops.
This study relies heavily on subjective criteria 
